Skip to main content
. Author manuscript; available in PMC: 2014 Feb 15.
Published in final edited form as: Clin Cancer Res. 2012 Dec 18;19(4):855–864. doi: 10.1158/1078-0432.CCR-12-2746

Table 3.

Time to tumorgraft quadrupling (d) under control conditions and after radiation (2 Gy twice weekly × 4), cisplatin (0.2 mg/kg twice weekly × 4), or cetuximab (2 mg/kg twice weekly × 4). TGD = tumor growth delay, the mean percentage increase in time to tumor quadrupling for each treatment relative to control.

Ctrl Radiation Cisplatin Cetuximab
UW-SCC6 44 79 91.5 123
UW-SCC14 13 13 25 17.0
UW-SCC22 55 125 125 181
% TGD (Mean +/− SD) 169 +/− 53 209 +/− 14 247 +/− 84
HHS Vulnerability Disclosure